The company is bracing for revenue and margin erosion due to increased competition and government pricing regulations like the IRA's Medicare negotiation program, making cost control and operational efficiency critical.
Filing excerpt
the expected impact of patent expiries and generic and biosimilar competition; the expected pricing pressures on our products and the anticipated impact to our business; the expected impact of the IRA Medicare Part D Redesign;
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
Competitors
Regions named
sec-10kpricingPressureGet every 10-K signal for Pfizer and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Pfizer this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/d67d503a-0249-4222-b175-b760c5c2333e returns this record as JSON. POST /v1/companies/enrich returns every signal for pfizer.com.
{
"signal_id": "d67d503a-0249-4222-b175-b760c5c2333e",
"signal_type": "sec-10k",
"signal_subtype": "pricingPressure",
"detected_at": "2026-03-03T05:50:18.893+00:00",
"company": {
"name": "Pfizer",
"domain": "pfizer.com"
},
"data": {
"detail": "The company is bracing for revenue and margin erosion due to increased competition and government pricing regulations like the IRA's Medicare negotiation program, making cost control and operational efficiency critical.",
"metrics": {
"timeframe": "multi_year"
},
"summary": "Pfizer faces significant pricing pressure from patent expiries, generics, and the Inflation Reduction Act (IRA).",
"excerpts": "the expected impact of patent expiries and generic and biosimilar competition; the expected pricing pressures on our products and the anticipated impact to our business; the expected impact of the IRA Medicare Part D Redesign;",
"relevance": 0.9,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/78003/000007800326000026/pfe-20251231.htm",
"filing_date": "2026-02-26",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Cost optimization needed",
"signal_category": "market",
"regions_mentioned": [
"U.S."
],
"competitors_mentioned": [
"Viatris",
"Mylan"
],
"technologies_mentioned": [
"biosimilars"
]
}
}
curl https://signals.autobound.ai/v1/signals/d67d503a-0249-4222-b175-b760c5c2333e \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"pfizer.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.